Enteral Nutrition Clinical Trial
Official title:
Early Exclusive Enteral Nutrition in Stable Preterm Infants at 30 0/7 - 33 6/7 Weeks Gestation: A Randomized Controlled Trial
Verified date | April 2024 |
Source | University of Calgary |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Enteral nutrition in preterm infants is usually started and advanced slowly until reaching full enteral feeds. Most preterm infants born before 34 weeks gestation require parenteral fluids to maintain normal blood sugar level and prevent excessive weight loss and dehydration. Availability of donor human milk (DHM) along with low incidence of necrotizing enterocolitis (NEC) in preterm infants born at 30-33 weeks have encouraged neonatologists to start feeding early and advance it faster in order to shorten time on parenteral nutrition (PN) and minimize the need for intravenous access. The objectives of this trial is to study whether exclusive enteral nutrition from day of birth (i.e. no PN) results in shorter time to achieve full enteral feed when compared with traditional feeding regimen that involves a combination of PN and progressive enteral feeding.
Status | Completed |
Enrollment | 69 |
Est. completion date | January 30, 2024 |
Est. primary completion date | October 24, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 48 Hours |
Eligibility | Inclusion Criteria: 1. Preterm infants born at 30 0/7 - 33 6/7 weeks gestation 2. Birth weight greater than 1000 g 3. Consent to use donor human milk 4. Postnatal age is less than 48 hours from birth 5. Infant is ready to start on feeding (as per clinical team) or feeding volume, when already started, is =12 ml/kg per day (total) and/or the infant received =2 feeds based on current feeding policy or physician descrition (total volume of the received feeds is =20 ml/kg per day). Exclusion Criteria: 1. Cord PH < 7.00 or Cord base access (BE) < -16 2. Apgar score < 7 at 5 minute 3. Lactate level =3 (if done for clinical indication) 4. Need for positive pressure ventilation (PPV) for >1 minute. 5. Hemodynamic instability (hypotension or poor perfusion at any time in this 48 hours) 6. Small for gestational age <3 percentile on Fenton chart and/or fetal absent or reversed umbilical arterial end-diastolic blood flow. 7. Major congenital malformation 8. Symptomatic or severe hypoglycemia (blood glucose <1.8 mmol/L) 9. Infants with moderate to severe respiratory distress. |
Country | Name | City | State |
---|---|---|---|
Canada | Foothills Medical Centre | Calgary | Alberta |
Canada | Peter Lougheed Hospital | Calgary | Alberta |
Canada | South Health Campus | Calgary | Alberta |
Lead Sponsor | Collaborator |
---|---|
Belal Alshaikh |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Duration to achieve of full enteral feeds in days | Day of life to achieve full enteral feeding defined as 140 ml/kg/day which is sustained for at least 3 days | Till 30 days of life | |
Secondary | Length of hospital stay | Length of hospital stay in days | At discharge from neonatal intensive care unit (NICU), up to 90 days of life | |
Secondary | Feeding intolerance | Presence of one or more of the following:
vomiting more than 2 times during any 24 h period, any episode of bile- or blood-stained vomiting, abdominal wall erythema or tenderness that resulted in cessation of feed. |
Till 30 days of life | |
Secondary | Incidence of late onset sepsis | Any microbial growth in blood, cerebrospinal fluid or urine after 72 hours of admission in NICU | At discharge from NICU, up to 90 days of life | |
Secondary | Incidence of NEC | Any Stage II and above according to Bell's staging criteria | At discharge from NICU, up to 90 days of life | |
Secondary | Incidence of hypoglycemia | Defined as point of care testing Glucose < 2.6 mmol/L at any time after rollment in study | Till 30 days of life |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02913677 -
Prolonged Minimal Enteral Nutrition Versus Slowly Advancing Enteral Nutrition in Very Low Birth Weight Infants:
|
N/A | |
Not yet recruiting |
NCT00916591 -
Prokinetic Drugs and Enteral Nutrition
|
N/A | |
Completed |
NCT01025167 -
The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer Patients
|
N/A | |
Not yet recruiting |
NCT05900323 -
Enteral Nutrition Guidelines and Patients' Outcomes
|
N/A | |
Completed |
NCT03153397 -
Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial)
|
N/A | |
Completed |
NCT02353689 -
The Effect of FODMAP Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement
|
Phase 2/Phase 3 | |
Terminated |
NCT00564655 -
Regional Anesthesia Block of the Transversus Abdominis Plane in Children Undergoing Gastric Tube Insertion
|
Phase 3 | |
Completed |
NCT06134674 -
Early Versus Delayed Enteral Nutrition in Critically Ill Adults With COVID-19
|
||
Recruiting |
NCT03791866 -
The Th9/IL-9 and Early Enteral Nutrition in Sepsis
|
N/A | |
Enrolling by invitation |
NCT06161350 -
The Multi-disciplinary Approach of Children With Feeding Difficulties and Tube Feeding in UZB Between 2000 and 2021
|
||
Active, not recruiting |
NCT02724631 -
TubeClear® Evaluation in Pediatric Patients (Phase I)
|
N/A | |
Completed |
NCT01988792 -
Human Milk Fortification in Very Low Birth Neonates
|
N/A | |
Completed |
NCT00600678 -
Gastric Emptying Study After Administration of a High Caloric Sip Feed
|
N/A | |
Completed |
NCT02998931 -
Trial of Enteral Glutamine on Clinical Outcomes in Critically Ill Patients
|
Phase 3 | |
Not yet recruiting |
NCT06411873 -
The Effect of High Protein Enteral Nutrition on Critically Ill Postoperative Children
|
N/A | |
Recruiting |
NCT03176875 -
Comparison of Partial and Exclusive Enteral Nutrition in the Treatment of Active Childhood-onset Crohn's Disease
|
N/A | |
Completed |
NCT02779335 -
Enteral Formula Tolerance in Pediatric Patients
|
N/A | |
Completed |
NCT05411848 -
2kcal Tube Feed Study
|
N/A | |
Completed |
NCT04868318 -
The Impact of Intervention With High-protein Enteral Formula in SICU.
|
N/A | |
Withdrawn |
NCT04601571 -
Confirming Feeding Tube Position Using CORTRAK
|
N/A |